An outside of the united states (ous) customer contacted the siemens customer care center to report an atellica im prolactin (prl) result within the non-pregnant female interval range for a patient that was considered discordant when compared to the higher result from an alternate method.The calibration was acceptable, and the quality control (qc) results were within the range.The ifu states in the interpretation of results section: "results of this assay should always be interpreted in conjunction with patient's medical history, clinical presentation and other findings." siemens healthcare diagnostics is investigating.
|
The initial mdr 1219913-2023-00015 was filed on january 17, 2023.An outside of the united states (ous) customer contacted the siemens customer care center to report an atellica im prolactin (prl) result within the non-pregnant female interval range for a patient that was considered discordant when compared to the higher result from an alternate method.March 24, 2023 additional information: siemens has investigated.The results for the sample from the alternate method assay testing were above the expected value for a non-pregnant patient.This is contrary to the patient history of a non-pregnant female and therefore should be considered the questionable results.There is no indication that the atellica im prolactin (prl) assay result produced was not correct based on the information about the patient provided.The analytical measuring range (amr) for the alternate method and the atellica im prolactin (prl) assay are different.The analytical measuring range (amr) for the alternate method is up to 470 ng/ml (0.0470-470 ng/ml) whereas the amr for the atellica im prl assay only goes up to 200 ng/ml (0.30-200.00 ng/ml) per the ifu 11200387_en rev.04, 2020-06.The results for the patient are not comparable with a one-to-one correlation due to the differences in the amr.The atellica im prl qc and calibration were verified by local team and deemed acceptable.The qc or calibration data was not provided to siemens for review.Based on the investigation, no product problem was identified.The customer is operational.
|